Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!
A key technical and strategic leader within the Pharmaceutical Development organization, responsible for leading outsourced drug product development and manufacturing activities across early- and late-phase development, commercial readiness, and lifecycle management. This individual will serve as the primary technical and strategic lead for CDMO partners supporting drug product manufacturing and testing, and will be accountable for defining, planning, coordinating, and driving manufacturing-related activities from formulation and process development through technology transfer, process validation, continued process verification, and commercial supply readiness.
This role requires deep technical expertise in drug product process development, formulation development, technology transfer, scale-up, process validation, and continued process verification, combined with the ability to provide senior-level oversight in a virtual manufacturing environment. The Director will lead CDMO governance and technical decision-making, influence cross-functional CMC strategy, and ensure that external manufacturing partners are aligned with program timelines, quality expectations, regulatory requirements, and commercial-readiness objectives.
The Director will also lead secondary packaging development activities in support of late-stage and commercial-readiness programs, ensuring alignment of packaging design, qualification, supply readiness, labeling configuration, validation, and execution within program timelines and regulatory expectations.
Key Responsibilities
Required Qualifications
Preferred Qualifications
Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee’s geographic location.
Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including: